Retroperitoneal Fibrosis in a Patient with Parkinsonʼs Disease Treated with Pergolide
- 1 June 1995
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 18 (3) , 277-279
- https://doi.org/10.1097/00002826-199506000-00009
Abstract
We describe a 68-year-old patient with Parkinson's disease who developed retroperitoneal fibrosis during pergolide treatment. Because pergolide is an ergot derivative, it could be related to the development of this complication.Keywords
This publication has 0 references indexed in Scilit: